JP5214272B2 - New microorganism - Google Patents
New microorganism Download PDFInfo
- Publication number
- JP5214272B2 JP5214272B2 JP2008045185A JP2008045185A JP5214272B2 JP 5214272 B2 JP5214272 B2 JP 5214272B2 JP 2008045185 A JP2008045185 A JP 2008045185A JP 2008045185 A JP2008045185 A JP 2008045185A JP 5214272 B2 JP5214272 B2 JP 5214272B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- gas
- strain
- ethanol
- carbon dioxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 244000005700 microbiome Species 0.000 title claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 65
- 239000007789 gas Substances 0.000 claims description 26
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 24
- 239000001569 carbon dioxide Substances 0.000 claims description 12
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 12
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 10
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 241001331543 Veillonella sp. Species 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000011156 evaluation Methods 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 239000002253 acid Substances 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 12
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 8
- 241001148134 Veillonella Species 0.000 description 7
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- 241000193403 Clostridium Species 0.000 description 5
- 229930091371 Fructose Natural products 0.000 description 5
- 239000005715 Fructose Substances 0.000 description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000186566 Clostridium ljungdahlii Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000005431 greenhouse gas Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000013081 phylogenetic analysis Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 241001468161 Acetobacterium Species 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108010082340 Arginine deiminase Proteins 0.000 description 1
- 101710180684 Beta-hexosaminidase Proteins 0.000 description 1
- 101710124976 Beta-hexosaminidase A Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- GUBGYTABKSRVRQ-UHFFFAOYSA-N D-Cellobiose Natural products OCC1OC(OC2C(O)C(O)C(O)OC2CO)C(O)C(O)C1O GUBGYTABKSRVRQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- KOSRFJWDECSPRO-WDSKDSINSA-N Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O KOSRFJWDECSPRO-WDSKDSINSA-N 0.000 description 1
- 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
- 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- LESXFEZIFXFIQR-LURJTMIESA-N Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)NCC(O)=O LESXFEZIFXFIQR-LURJTMIESA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241000718543 Ormosia krugii Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102100030122 Protein O-GlcNAcase Human genes 0.000 description 1
- 101710081801 Protein O-GlcNAcase Proteins 0.000 description 1
- 101710199095 Putative beta-hexosaminidase Proteins 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 241001533207 Veillonella atypica Species 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000002407 reforming Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明は新規な微生物に関し、詳しくは一酸化炭素、または二酸化炭素と水素を基質として、エタノールを生成する能力を有する新種の微生物に関する。 The present invention relates to a novel microorganism, and more particularly to a new kind of microorganism having the ability to produce ethanol using carbon monoxide or carbon dioxide and hydrogen as substrates.
温暖化対策や、化石燃料の消費抑制のため、新たなエネルギーに関する研究が進められている。 Research on new energy is being promoted to combat global warming and reduce consumption of fossil fuels.
産業廃ガスや木質系バイオマスのガス化・改質にともなって排出されるガスに含まれる気体状の二酸化炭素や一酸化炭素などを原料として、微生物による発酵を行い、酢酸やエタノールなどの有用物を回収する技術がある。 Useful materials such as acetic acid and ethanol are fermented by microorganisms using gaseous carbon dioxide and carbon monoxide, etc. contained in the gas discharged from the gasification and reforming of industrial waste gas and woody biomass. There is a technology to recover.
特に、エタノールは近年、燃料としての需要が高まっており、有用物としての価値が高い。さらに、二酸化炭素は温暖化ガスのひとつであるので、二酸化炭素を炭素源として利用できる菌が得られれば、温暖化ガスの削減効果が期待できる。
二酸化炭素や一酸化炭素を基質として酢酸やエタノールなどの有用物を生産する微生物としては、主にクロストリジウム属菌が知られているに過ぎなかった(特許文献1〜4)。 As microorganisms that produce useful substances such as acetic acid and ethanol using carbon dioxide and carbon monoxide as substrates, only the genus Clostridium has been known (Patent Documents 1 to 4).
本発明者らは、微生物の単離とスクリーニングを重ね、二酸化炭素や一酸化炭素を基質として、エタノールを生成する能力を有する微生物を選抜し、本発明を完成させるに至った。 The present inventors have repeated the isolation and screening of microorganisms, selected microorganisms having the ability to produce ethanol using carbon dioxide and carbon monoxide as a substrate, and completed the present invention.
すなわち、本発明の課題は、エタノールを生成する能力を有する新規微生物を提供することにある。 That is, the subject of this invention is providing the novel microorganisms which have the capability to produce | generate ethanol.
本発明の他の課題は以下の記載によって明らかになる。 The other subject of this invention becomes clear by the following description.
上記課題は以下の各発明によって解決される。 The above problems are solved by the following inventions.
(請求項1)
一酸化炭素、または二酸化炭素と水素からなる合成ガスを基質として導入し、嫌気的環境下で、エタノール生成能を有する、Veillonella sp. Strain M9(寄託番号NITE P−472)として独立行政法人製品評価技術基盤機構特許微生物寄託センターに寄託されている新規微生物。
(Claim 1)
Introducing carbon monoxide or synthesis gas consisting of carbon dioxide and hydrogen as a substrate, and having the ability to produce ethanol in an anaerobic environment , Veillonella sp. A novel microorganism deposited as a strain M9 (deposit number NITE P-472) at the Patent Microorganism Depositary, National Institute of Technology and Evaluation .
本発明によれば、エタノール生成能を有する新規微生物を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the novel microorganisms which have ethanol production ability can be provided.
以下、本発明の実施の形態を説明する。 Embodiments of the present invention will be described below.
本発明のバイロネラ(Veillonella)属に属する新規微生物は、以下、必要に応じて「本菌株」と称する。 The novel microorganism belonging to the genus Veillonella of the present invention is hereinafter referred to as “the present strain” as necessary.
本菌株は、福岡市下水処理場のメタン発酵処理分画より単離した菌株であり、二酸化炭素や一酸化炭素を基質として酢酸の他にエタノールを生成する能力を持つ、バイロネラ(Veillonella)属に属する新種である。 This strain is a strain isolated from the methane fermentation treatment fraction of Fukuoka City Sewage Treatment Plant, and has the ability to produce ethanol in addition to acetic acid using carbon dioxide or carbon monoxide as a substrate. It is a new species to which it belongs.
本菌株は、Veillonella sp. Strain M9(寄託番号NITE P−472)として独立行政法人製品評価技術基盤機構特許微生物寄託センターに寄託されており、以下のような性質を有する。なお、+は陽性又は有を示し、−は陰性又は無を示している。 This strain is Veillonella sp. It has been deposited as Strain M9 (deposit number NITE P-472) at the Patent Microorganism Deposit Center, National Institute of Technology and Evaluation, and has the following properties. In addition, + shows positive or existence,-shows negative or nothing.
A.形態的性質
(1)細胞の形及び大きさ:約0.3μmの球菌
(2)運動性の有無:−
(3)胞子の有無:−
A. Morphological properties (1) Cell shape and size: about 0.3 μm of cocci
(3) Spore presence:
B.培養的性質
(1)Clostridium ljungdahlii(CL)培地寒天平板培養(※1)
37℃、培養日数2日で直径1〜2mmの円形のコロニーを形成する
i)色:白色
ii)表面の形状:スムーズ
iii)透明度:半透明
iv)変異によるコロニー形態の変化:−
v)培養条件や生理的状態によるコロニー形態の変化:−
※1 C.ljungdahlii培地の培地組成を下記に示す。
NH4Cl 1.00g
KCl 0.10g
MgSO4 0.20g
NaCl 0.80g
KH2PO4 0.10g
CaCl2 0.02g
Na2WO4 0.20mg
Yeast Extract 1.00g
NaHCO3 1.00g
Fructose 5.00g
Cysteine−HCl 0.30g
Na2S 0.30g
Trace element solution(I) 10ml
Vitamin solution (II) 10ml
Distilled water 1000ml
Agar 15g
pH 5.9
なお、上記の(I)Trace element solution及び(II)Vitamin solutionは以下の組成である。
(I)Trace element solution
Nitrilotriacetic acid 1.5g
MgSO4 3.0g
MnSO4 0.5g
NaCl 1.0g
FeSO4 0.1g
CoSO4 0.18g
CaCl2 0.1g
ZnSO4 0.18g
CuSO4 0.01g
KAl(SO4)2 0.02g
H3BO3 0.01g
Na2MoO4 0.01g
NiCl2 0.025g
Na2SeO3 0.3mg
Distilled water 1000ml
(II)Vitamin solution
Biotin 2.0mg
Folic asid 2.0mg
Pyridoxine−HCl 10mg
Thiamine−HCl 5.0mg
Riboflavin 5.0mg
Nicotinic acid 5.0mg
D−Ca−pantothenate 5.0mg
Vitamin B12 0.1mg
P−Aminobenzoic acid 5.0mg
Lipoic acid 5.0mg
Distilled water 1000ml
(2)ゼラチン穿刺培養
i)ゼラチン液化:−
(3)リトマス・ミルク
i)反応:リトマス還元
ii)凝固:+
(4)B.C.P.ミルク
i)反応:アルカリ性
B. Culture properties (1) Clostridium ljungdahlii (CL) medium agar plate culture (* 1)
I) Color: white ii) Surface shape: smooth iii) Transparency: translucent iv) Change in colony morphology due to mutation: −
v) Changes in colony morphology due to culture conditions and physiological conditions:-
* 1 C.I. The medium composition of the ljungdahlii medium is shown below.
NH 4 Cl 1.00g
KCl 0.10g
MgSO 4 0.20 g
NaCl 0.80g
KH 2 PO 4 0.10 g
CaCl 2 0.02 g
Na 2 WO 4 0.20 mg
Yeast Extract 1.00g
NaHCO 3 1.00 g
Fructose 5.00g
Cysteine-HCl 0.30 g
Na 2 S 0.30 g
Trace element solution (I) 10ml
Vitamin solution (II) 10ml
Distilled water 1000ml
Agar 15g
pH 5.9
The above (I) Trace element solution and (II) Vitamin solution have the following compositions.
(I) Trace element solution
Nitritriacetic acid 1.5g
MgSO 4 3.0 g
MnSO 4 0.5g
NaCl 1.0g
FeSO 4 0.1g
CoSO 4 0.18 g
CaCl 2 0.1 g
ZnSO 4 0.18 g
CuSO 4 0.01g
KAl (SO 4 ) 2 0.02 g
H 3 BO 3 0.01 g
Na 2 MoO 4 0.01 g
NiCl 2 0.025g
Na 2 SeO 3 0.3 mg
Distilled water 1000ml
(II) Vitamin solution
Biotin 2.0mg
Folic asid 2.0mg
Pyridoxine-HCl 10mg
Thiamine-HCl 5.0mg
Riboflavin 5.0mg
Nicotinic acid 5.0mg
D-Ca-pantothenate 5.0mg
Vitamin B 12 0.1mg
P-Aminobenzoic acid 5.0mg
Lipic acid 5.0mg
Distilled water 1000ml
(2) Gelatin puncture culture i) Gelatin liquefaction:-
(3) Litmus milk i) Reaction: Litmus reduction ii) Coagulation: +
(4) B. C. P. Milk i) Reaction: Alkaline
C.生理学的性質
(1)グラム染色性:−
(2)硝酸塩の還元:+
(3)インドールの生成:−
(4)硫化水素の生成:−
(5)デンプンの加水分解:−
(6)ウレアーゼ:−
(7)カタラーゼ:−
(8)生育の範囲
i) 至適pH:7.2
ii)温度:20〜42℃で良好に生育
(9)酸素に対する態度:偏性嫌気性
(10)O−Fテスト:酸化型
(11)糖類からの酸及びガスの生成
i)L−アラビノース:酸(−)/ガス(−)
ii)D−キシロース:酸(−)/ガス(−)
iii)グルコース:酸(+)/ガス(−)
iv)D−マンノース:酸(−)/ガス(−)
v)フラクトース:酸(+)/ガス(−)
vi)マルトース:酸(−)/ガス(−)
vii)ラクトース:酸(−)/ガス(−)
viii)D−トレハロース:酸(−)/ガス(−)
ix)D−ソルビトール:酸(−)/ガス(−)
x)D−マンニトール:酸(−)/ガス(−)
xi)グリセリン:酸(−)/ガス(−)
xii)D−セロビオース:酸(−)/ガス(−)
xiii)エスクリン:酸(−)/ガス(−)
xiv)サリシン:酸(−)/ガス(−)
xv)D−メレチトース:酸(−)/ガス(−)
xvi)D−ラフィノース:酸(−)/ガス(−)
xvii)L−ラムノース:酸(+)/ガス(−)
C. Physiological properties (1) Gram staining:-
(2) Reduction of nitrate: +
(3) Production of indole:-
(4) Production of hydrogen sulfide:-
(5) Starch hydrolysis:-
(6) Urease:-
(7) Catalase:-
(8) Range of growth i) Optimum pH: 7.2
ii) Temperature: good growth at 20-42 ° C. (9) Attitude toward oxygen: obligate anaerobic (10) OF test: oxidized form (11) Acid and gas production from sugars i) L-arabinose: Acid (-) / Gas (-)
ii) D-xylose: acid (-) / gas (-)
iii) Glucose: acid (+) / gas (−)
iv) D-mannose: acid (−) / gas (−)
v) Fructose: acid (+) / gas (-)
vi) Maltose: acid (-) / gas (-)
vii) Lactose: acid (-) / gas (-)
viii) D-trehalose: acid (-) / gas (-)
ix) D-sorbitol: acid (-) / gas (-)
x) D-mannitol: acid (-) / gas (-)
xi) Glycerin: acid (-) / gas (-)
xii) D-cellobiose: acid (-) / gas (-)
xiii) esculin: acid (-) / gas (-)
xiv) Salicin: acid (−) / gas (−)
xv) D-meletitol: acid (-) / gas (-)
xvi) D-raffinose: acid (-) / gas (-)
xvii) L-rhamnose: acid (+) / gas (-)
D.酵素反応
i)アルギニンジヒドロラーゼ:+
ii)α−ガラクトシダーゼ:−
iii)β−ガラクトシダーゼ:−
iv)β−ガラクトシダーゼ−6−フォスフェート:−
v)α−グルコシダーゼ:−
vi)β−グルコシダーゼ:−
vii)α−アラビノシダーゼ:−
viii)N−アセチル−β−グルコサミニダーゼ:−
ix)グルタミン酸デカルボキシラーゼ:−
x)α−フッコシダーゼ:−
xi)アルカリフォスファターゼ:−
xii)アルギニンアリルアミダーゼ:−
xiii)p−プロリンアリルアミダーゼ:−
xiv)ロイシルグリシンアリルアミダーゼ:−
xv)フェニルアラニンアリルアミダーゼ:−
xvi)ロイシンアリルアミダーゼ:−
xvii)ピログルタミン酸アリルアミダーゼ:−
xviii)チロシンアリルアミダーゼ:−
xix)アラニンアリルアミダーゼ:−
xx)グリシンアリルアミダーゼ:−
xxi)ヒスチジンアリルアミダーゼ:−
xxii)グルタミルグルタミン酸アリルアミダーゼ:−
xxiii)セリンアリルアミダーゼ:−
D. Enzymatic reaction i) Arginine dihydrolase: +
ii) α-galactosidase: −
iii) β-galactosidase:-
iv) β-galactosidase-6-phosphate: −
v) α-glucosidase: −
vi) β-glucosidase: −
vii) α-arabinosidase:-
viii) N-acetyl-β-glucosaminidase:-
ix) glutamate decarboxylase:-
x) α-Fucosidase: −
xi) alkaline phosphatase:-
xii) Arginine allylamidase:-
xiii) p-proline allylamidase:-
xiv) Leucylglycine allylamidase:-
xv) Phenylalanine allylamidase:-
xvi) Leucine allylamidase:-
xvii) pyroglutamate allylamidase:-
xviii) tyrosine allylamidase:-
xix) Alanine allylamidase:-
xx) Glycine allylamidase:-
xxi) Histidine allylamidase:-
xxii) Glutamylglutamate allylamidase:-
xxiii) Serine allylamidase:-
E.16S rDNAの塩基配列に基づく分子系統解析
16S rDNAの塩基配列を決定し、DNAデータベース(DDBJ)にアクセスし、BRASTプログラムを用いて16S rDNAの塩基配列の相同性検索を行った結果、いずれのVeillonella属細菌とも16S rDNAの相同性が97%未満であった。
E. Molecular phylogenetic analysis based on the base sequence of 16S rDNA The base sequence of 16S rDNA was determined, the DNA database (DDBJ) was accessed, and the homology search of the base sequence of 16S rDNA was performed using the BRAST program. The homology of 16S rDNA with the genus bacteria was less than 97%.
F.分類・同定の結果
本菌株の表現形質による分類学的性質に基づき、Bergey’s Manual of Systematic Bacteriology,Vol.1,N.R.Krieg,J.G.Holt(ed),Williams&Wilkins,Baltimore(1984)およびBergey’s Manual of Determinate Bacteriology(9th ed.),J.G.Holt,N.R.Krieg,P.H.A.Sneath,J.T.Staley,S.T.Williams(ed),Williams&Wilkins,Baltimore(1994)を参考に分類・同定を行った結果、本菌株はVeillonella属と同定された。
F. Results of Classification / Identification Based on the taxonomic characteristics of this strain by the phenotypic traits, Bergey's Manual of Systematic Bacteriology, Vol. 1, N. R. Krieg, J .; G. Holt (ed), Williams & Wilkins, Baltimore (1984) and Bergey's Manual of Determination Bacteriology (9th ed.), J. Am. G. Holt, N .; R. Krieg, P.A. H. A. Sneath, J .; T.A. Staley, S.M. T.A. As a result of classification and identification with reference to Williams (ed), Williams & Wilkins, Baltimore (1994), this strain was identified as the genus Veillonella.
Veillonella属には基準種V.parvulaの他に、V.atypica、V.disapar、V.criceti、V.rattiなどが知られている。知られているVeillonella属菌は、V.cricetiにのみフルクトース発酵能があるが、一般的には糖類を発酵することなく、ピルビン酸や乳酸などの有機酸の発酵能を有するのみである。 In the genus Veillonella, the reference species V. In addition to parvula, V. atypica, V.M. disapar, V.D. criceti, V.M. ratti and the like are known. Known genus Veillonella is V. Only criceti has the ability to ferment fructose, but generally only has the ability to ferment organic acids such as pyruvic acid and lactic acid without fermenting sugars.
一方、本菌株は、フルクトースで生育可能(発酵能有)であり、さらにグルコースに対しても発酵能を有する点で他のVeillonella属菌と分類学的に異なる。 On the other hand, this strain can be grown on fructose (fermentable) and is taxonomically different from other Veillonella spp. In that it also has the ability to ferment glucose.
また、一般に、16S rDNAの塩基配列に基づく分子系統解析では、相同性が95%以上であれば同属、97%以上であれば類縁関係があり、99%以上であれば同種とみなすことができるとされている。 In general, molecular phylogenetic analysis based on the base sequence of 16S rDNA can be regarded as homologous if homology is 95% or higher, similar if 97% or higher, and homologous if 99% or higher. It is said that.
本菌株の16S rDNAの結果では、他のVeillonella属の菌との相同性は97%未満であったので、公知のVeillonella属菌株とは別の種であることが示された。 The 16S rDNA result of this strain was less than 97% homologous to other Veillonella bacteria, indicating that it was a different species from the known Veillonella strains.
本菌株は、グルコース、フラクトースから酢酸の他にエタノールを生成するほか、一酸化炭素、または二酸化炭素と水素を基質として、酢酸の他にエタノールを生成することを特徴とする。 This strain is characterized by producing ethanol in addition to acetic acid from glucose and fructose, and also producing ethanol in addition to acetic acid using carbon monoxide or carbon dioxide and hydrogen as substrates.
本菌株を用いて、エタノールを生産する方法は、特に限定されない。 The method for producing ethanol using this strain is not particularly limited.
一酸化炭素、または二酸化炭素と水素を基質として、エタノールを生産する方法としては、嫌気状態で、微生物に一酸化炭素、または二酸化炭素と水素からなる合成ガスを供給して行う方法が挙げられる。 Examples of a method for producing ethanol using carbon monoxide or carbon dioxide and hydrogen as substrates include a method in which an anaerobic state is performed by supplying a microorganism with a synthesis gas composed of carbon monoxide or carbon dioxide and hydrogen.
エタノール生成機構は以下の通りである。 The ethanol production mechanism is as follows.
図1は本菌株が備えていると考えられているエタノール生成経路の模式図である。 FIG. 1 is a schematic diagram of an ethanol production pathway that is considered to be included in this strain.
この経路をもつ多くの微生物は、アセチルCoAから、酢酸または細胞を形成する有機物を生成するのみであるが、本菌株は、酢酸の他にエタノールも生成することができる。 Many microorganisms with this pathway only produce acetic acid or organic matter that forms cells from acetyl CoA, but this strain can also produce ethanol in addition to acetic acid.
以下に本発明の実施例を説明するが、本発明はかかる実施例によって限定されない。 Examples of the present invention will be described below, but the present invention is not limited to such examples.
実施例1
本菌株によるエタノール生成能を確認した。
Example 1
Ethanol production ability by this strain was confirmed.
まず、本菌株を接種した滅菌済CL培地20mlを50ml耐圧バイアルに入れCO/CO2ガス(CO:CO2=8:2)を封入し、150rpmで振とうしながら37℃で24〜48時間培養し、培養液を作製した。 First, 20 ml of sterilized CL medium inoculated with this strain was placed in a 50 ml pressure-resistant vial, CO / CO 2 gas (CO: CO 2 = 8: 2) was sealed, and the mixture was shaken at 150 rpm for 24 to 48 hours at 37 ° C. Culture was performed to prepare a culture solution.
培養液を、図2に示す実験装置(発酵槽の実効体積1L)に加圧状態のまま移し、CO/CO2ガスを再封入した。pHを7.0、温度37℃、攪拌を100rpmとし、CO/CO2ガス循環が0.1vvmの条件で3日間エタノール生成実験を行った。 The culture solution was transferred to the experimental apparatus shown in FIG. 2 (fermentor effective volume 1 L) while being pressurized, and CO / CO 2 gas was re-encapsulated. An ethanol production experiment was conducted for 3 days under conditions of pH 7.0, temperature 37 ° C., stirring 100 rpm, and CO / CO 2 gas circulation 0.1 vvm.
微生物の細胞1gにつき、1日あたり0.22gのエタノールを得ることができた。 It was possible to obtain 0.22 g of ethanol per 1 g of microbial cells per day.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008045185A JP5214272B2 (en) | 2008-02-26 | 2008-02-26 | New microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008045185A JP5214272B2 (en) | 2008-02-26 | 2008-02-26 | New microorganism |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009201389A JP2009201389A (en) | 2009-09-10 |
JP2009201389A5 JP2009201389A5 (en) | 2010-11-18 |
JP5214272B2 true JP5214272B2 (en) | 2013-06-19 |
Family
ID=41144277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008045185A Expired - Fee Related JP5214272B2 (en) | 2008-02-26 | 2008-02-26 | New microorganism |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5214272B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5410685B2 (en) * | 2008-02-26 | 2014-02-05 | 三井造船株式会社 | Ethanol production method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0634728B2 (en) * | 1987-10-12 | 1994-05-11 | 工業技術院長 | Method for producing acetic acid |
US5173429A (en) * | 1990-11-09 | 1992-12-22 | The Board Of Trustees Of The University Of Arkansas | Clostridiumm ljungdahlii, an anaerobic ethanol and acetate producing microorganism |
ES2216506T3 (en) * | 1999-05-07 | 2004-10-16 | Emmaus Foundation, Inc. | CLOSTRIDUM STRAINS THAT PRODUCE ETHANOL FROM GASES CONTAINING SUBSTRATES. |
JP2003339371A (en) * | 2002-05-29 | 2003-12-02 | Cosmo Oil Co Ltd | New ethanol-producing bacteria and method for producing ethanol |
-
2008
- 2008-02-26 JP JP2008045185A patent/JP5214272B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2009201389A (en) | 2009-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Asada et al. | Hydrogen production by co-cultures of Lactobacillus and a photosynthetic bacterium, Rhodobacter sphaeroides RV | |
Lo et al. | Dark fermentative hydrogen production with crude glycerol from biodiesel industry using indigenous hydrogen-producing bacteria | |
US20090137013A1 (en) | Microorganisms and methods for increased hydrogen production using diverse carbonaceous feedstock and highly absorptive materials | |
He et al. | Hydrogen photosynthesis by Rhodobacter capsulatus and its coupling to a PEM fuel cell | |
Sinha et al. | Biohydrogen production from various feedstocks by Bacillus firmus NMBL-03 | |
CN108603201A (en) | Integrate fermentation and electrolysis process | |
US20060051848A1 (en) | Novel ethanol producing bacterium and process for producing ethanol | |
BRPI0820556B1 (en) | bacteria and methods for their use | |
Jayasinghearachchi et al. | Fermentative hydrogen production by new marine Clostridium amygdalinum strain C9 isolated from offshore crude oil pipeline | |
He et al. | Kinetic analysis of photosynthetic growth and photohydrogen production of two strains of Rhodobacter capsulatus | |
JPH04169186A (en) | Production of hydrogen by utilization of microorganism | |
Verma et al. | Isolation and characterization of a novel photoheterotrophic strain ‘Rubrivivax benzoatilyticus TERI-CHL1’: Photo fermentative hydrogen production from spent effluent | |
Kobayashi et al. | Efficient hydrogen production from acetate through isolated Rhodobacter sphaeroides | |
Subudhi et al. | Photo fermentative hydrogen production by a new strain; Rhodobacter sphaeroides CNT 2A, isolated from pond sediment | |
Jayasinghearachchi et al. | Fermentative hydrogen production by two novel strains of Enterobacter aerogenes HGN-2 and HT 34 isolated from sea buried crude oil pipelines | |
Ersoy et al. | Comparative evaluation of the biohydrogen production potential of thermophilic microorganisms isolated from hot springs located in Izmir | |
WO2014133668A1 (en) | A butyrate producing clostridium species, clostridium pharus | |
El-Rab et al. | Costless and huge hydrogen yield by manipulation of iron concentrations in the new bacterial strain Brevibacillus invocatus SAR grown on algal biomass | |
Khalil et al. | A robust and efficient bioprocess of hydrogen production from crude glycerol by Clostridium beijerinckii G117 | |
JP5410685B2 (en) | Ethanol production method | |
JP5214272B2 (en) | New microorganism | |
JP5248139B2 (en) | New microorganism | |
JP5403612B2 (en) | New hydrogen-producing bacteria | |
CN109825459B (en) | Dissimilatory iron reduction bacterium for coupling hydrogen production | |
Manikkandan et al. | Microbial production of Hydrogen from sugarcane Bagasse using Bacillus Sp |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100930 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100930 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20101001 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121218 |
|
R155 | Notification before disposition of declining of application |
Free format text: JAPANESE INTERMEDIATE CODE: R155 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130227 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160308 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees | ||
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |